Similar studies have also shown that the expression of VDR in the subgroup of severe fibrosis was lower than that of the subgroup of mild fibrosis in genotype I HCV patients, and similar findings were found in patients with nonalcoholic fatty hepatitis (NASH) [37,38]. This evidence concerns the gene VDR and metabolic dysfunction-associated steatohepatitis.